副教授

个人介绍：

林海树，副教授，1997年本科毕业于中山大学，2002年在新加坡国立大学药学系获博士学位，之后在新加坡、澳大利亚、法国从事博士后研究工作。2012年至2020年，担任新加坡国立大学药学系助理教授。2021年元月，全职加入深圳技术大学药学院。

林海树博士长期从事药物分析、药物代谢动力学及抗炎药理研究，最近十年，科研主要聚焦于白藜芦醇的天然衍生物。至今累计获取科研经费超过四百万人民币；在国际核心学术期刊British Journal of Pharmacology、Molecular Nutrition & Food Research及Rheumatology等杂志发表60余篇研究论文；H-index为23，累计引用超过2000次；博士研究生毕业5名；担任Frontiers in Pharmacology的Associate Editor，International Journal of Environmental Research and Public Health的编委及80余个学术期刊的审稿人。

代表作：

Boateng-Marfoa Y, Dong YC, Ng WK^*,Lin HS^*(2021) Artemether-Loaded Zein Nanoparticles: An Innovative Intravenous Dosage Form for the Management of Severe Malaria.Int J Mol Sci22：1141.(IF: 5.923)

Dai Y, Lim JX, Yeo SCM, Xiang XQ, Tan KS, Fu JH，Huang LZ,Lin HS^*(2020) Biotransformation of piceatannol, a dietary resveratrol derivative: Promises to human Health.Mol Nutr Food Res64: e1900905. (IF: 5.914) (当期封面文章)

Dai Y, Yeo SCM, Barnes PJ, Donnelly LE, Loo LC,Lin HS^*(2018): Pre-clinical Pharmacokinetic and Metabolomic Analyses of Isorhapontigenin, a Dietary Resveratrol Derivative.Front Pharmacol9: 753. (IF: 5.810)

Yeo SCM, Fenwick PS, Barnes PJ,Lin HS^*, Donnelly LE^*(2017): Isorhapontigenin, a bioavailable dietary polyphenol, suppresses airway epithelial cell inflammation through a corticosteroid-independent mechanism.Br J Pharmacol174: 2043–2059. (Impact Factor: 8.739) (此文入选Editor’s Choice)

Yeo SCM, Ho PC,Lin HS^*(2013): Pharmacokinetics of pterostilbene in Sprague-Dawley rats: The impacts of aqueous solubility, fasting, dose escalation, and dosing route on bioavailability.Mol Nutr Food Res57: 1015-25. (IF: 5.914)

Kong ST,Lin HS^#, Ching JH, Ho PC (2011): Evaluation of dried blood spots (DBS) as sample matrix for gas chromatography–mass spectrometry (GC-MS) based metabolomic profiling.Anal Chem83: 4314-4318. (Impact Factor: 6.986)

Choo QY, Ho PC, Tanaka Y,Lin HS^*(2010): Histone deacetylase inhibitors MS-275 and SAHA induced growth arrest and suppressed lipolysaccharide-stimulated NF-κB p65 nuclear accumulation in human rheumatoid arthritis synovial fibroblastic E11 cells.Rheumatology49: 1447-1460. (Impact Factor: 7.58)

Lin HS^#, Hu CY^#, Chan HY, Liew YY, Huang HP, Lepescheux L, Bastianelli E, Baron R, Rawadi G, Clement-Lacroix P (2007): Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents.Br J Pharmacol150:862-872. (Impact Factor: 8.739) (此文入选Editor’s Choice,自发表以来，“他引”超过250次)

^*:通讯作者；^#：共同第一作者

联系方式：

linhaishu@sztu.edu.cn